Regulatory aspects of integration of pharmacogenetics into drug development

被引：0
|
作者：
Shah R.R. [1 ]
机构：
[1] Pharmacogenetics Working party, Regulatory Sub-group
来源：
International Journal of Pharmaceutical Medicine | 2001年 / 15卷 / 2期
关键词：
Debrisoquine; Narrow Therapeutic Index; CYP2D6 Activity; Drug Development Programme; Metabolic Elimination;
D O I：
10.1097/00124363-200104000-00007
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：67 / 69
页数：2
相关论文
共 50 条
  • [1] Pharmacogenetics in drug development: Regulatory and clinical considerations
    Hall, ST
    Abbott, N
    Schmith, G
    Brazell, C
    DRUG DEVELOPMENT RESEARCH, 2004, 62 (02) : 102 - 111
  • [2] Integration of Pharmacogenetics and Pharmacogenomics in Drug Development: Implications for Regulatory and Medical Decision Making in Pediatric Diseases
    Piana, Chiara
    Surh, Linda
    Furst-Recktenwald, Sabine
    Iolascon, Achille
    Jacqz-Aigrain, Evelyne M.
    Jonker, In Eke
    Russo, Roberta
    van Schalk, Ron H. N.
    Wessels, Judith
    Della Pasqua, Oscar E.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 (05): : 704 - 716
  • [3] Pharmacogenetics and drug development
    Reiser, H
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 40, 2005, 40 : 417 - 427
  • [4] Pharmacogenetics in drug development
    Becquemont, L.
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2011, 15 (05): : 156 - 160
  • [5] PHARMACOGENETICS AND DRUG DEVELOPMENT
    Beaune, P.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 4 - 5
  • [6] Pharmacogenetics in drug development
    McCarthy, AD
    Kennedy, JL
    Middleton, LT
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2005, 360 (1460) : 1579 - 1588
  • [7] Understanding the Relative Roles of Pharmacogenetics and Ontogeny in Pediatric Drug Development and Regulatory Science
    Leeder, J. Steven
    Kearns, Gregory L.
    Spielberg, Stephen P.
    van den Anker, John
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (12): : 1377 - 1387
  • [8] Pharmacogenetics in drug development and pharmacovigilance
    Roses, A. D.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 33 - 33
  • [9] Applying pharmacogenetics in drug development
    Roses, AD
    DRUG DEVELOPMENT RESEARCH, 2004, 62 (02) : 79 - 80
  • [10] Ophthalmic Drug Discovery and Development: Regulatory Aspects of Patient Focused Drug Development in Ophthalmology
    Cheryl L. Rowe-Rendleman
    Pharmaceutical Research, 2019, 36
12345